Skip to main navigation Skip to search Skip to main content

The Addition of Gemtuztumab Ozogamicin to Low Dose Ara C Improves Remission Rates but Not Survival Results of the UK LRF AML14 and NCRI AML16

  • Christine Burnett
  • , R. Hills
  • , A.E. Hunter
  • , D. Milligan
  • , W.J. Kell
  • , K. Wheatley
  • , J. Yin
  • , Mary Frances McMullin
  • , H. Dignum
  • , Linda Bowen
  • , Norman Russell

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)13-14
Number of pages2
JournalBlood
Volume116
Publication statusPublished - 2010

Cite this